Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV
- Yu Jen Chang
- , Uyen Nguyen Phuong Le
- , Jia Jun Liu
- , Sin Rong Li
- , Shao Ting Chao
- , Hsueh Chou Lai
- , Yu Feng Lin
- , Kai Cheng Hsu
- , Chih Hao Lu
- , Cheng Wen Lin
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery
- TMU Research Center of Cancer Translational Medicine
- TMU Research Center of Drug Discovery
- Master Program in Clinical Genomics and Proteomics
- International Ph.D. Program for Translational Science
- Ph.D. Program in Drug Discovery and Development Industry
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- Taipei Medical University
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Citations
(Scopus)